SMS Pharmaceuticals (SMSPHARMA) — Announcement

📢 Key Event
CARE Ratings reaffirms and upgrades SMS Pharmaceuticals' credit rating to 'CARE A' stable with enhanced facility size.

🔄 What Changed
Long-term rating outlook revised from Positive to Stable; long-term facility amount increased from ₹350.87 crores to ₹570.07 crores.

💡 Investor Takeaway
The upgrade reflects stronger lender confidence and a more stable outlook, potentially lowering future funding costs.

SMS Pharmaceuticals announced that CARE Ratings reaffirmed its 'CARE A' stable rating for long-term bank facilities and 'CARE A1' for short-term facilities, upgrading the long-term rating from 'Positive' to 'Stable' and enhancing the facility amount to ₹570.07 crores from ₹350.87 crores. The credit rating action underscores improved financial performance and operational stability, signaling stronger lender confidence in the company's debt servicing capacity.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SMSPHARMA ✨ Ask AI About This

About SMS Pharmaceuticals Ltd (SMSPHARMA)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹3,437.97 Cr P/E: 32.7 ROE: 14.3% ROCE: 15.2% Div Yield: 0.11%

View full SMSPHARMA stock details →

📡 Get AI alerts when SMSPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SMSPHARMA — Free

💡 Ask AI about this filing

"How does the revised rating outlook affect SMSPHARMA's cost of capital?" "What specific financial metrics drove the rating upgrade?" "How does this rating compare to peers in the pharmaceutical sector?"

Ask AI Free →

📊 More SMSPHARMA filings

See all SMSPHARMA filings →

🔥 Also filed on 2 September 2026

532113 Brijlaxmi Leasing & Finance Ltd Annual Report BEML BEML Ltd Announcement KARURVYSYA Karur Vysya Bank Ltd Announcement MPHASIS Mphasis Ltd Announcement ICICIBANK ICICI Bank Ltd Announcement CGCL Capri Global Capital Ltd Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SMSPHARMA files new disclosures

Track SMSPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SMSPHARMA — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd